The AMRIPRAZ brand, founded in 2011 (Switzerland), from 2951 sister brands and 17477 competing brands. AMRIPRAZ is owned by NOVARTIS N, listed on the stock exchange of Zurich The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. AMRIPRAZ is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(AMRIPRAZ)
over 5 years*
CHF 102.45